Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1643 1649 1675
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19433400 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND A PROCESS FOR PREPARATION | Non-Final OA | PHARMAZZ, INC. |
| 18258758 | AMYLOID-SPECIFIC ANTIBODIES AND USES THEREOF | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 17759792 | PH-SENSITIVE FC VARIANTS | Non-Final OA | Korea University Research and Business Foundation |
| 18248778 | COMBINATORIAL IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR PANCREATIC DUCTAL ADENOCARCINOMA TREATMENT | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18011807 | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS | Non-Final OA | Alexion Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy